NCT06295783 Prospective Evaluation of the Relation Between Different Questionnaires Measuring Radiation-induced Side-effect
| NCT ID | NCT06295783 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Radiation |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-06-10 |
| Primary Completion | 2027-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2024-06-10 with a primary completion date of 2027-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To learn more about how you would rate the intensity or severity of your symptoms during or after radiation therapy using questionnaires with different rating scales.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * English as a primary language * Participants with a diagnosis of HNC undergoing active curative RT or having received curative RT within the past 5 years at MD Anderson * Ability to complete the survey(s) of their own volition Exclusion Criteria: * Age \< 18 years * Non-English speaking participants * Participants who are receiving or have received RT in a non-HN site. * Participants in follow up and over 5 years from post-treatment * Neurocognitive deficits that render patients unable to complete the survey(s) on their own.
Contact & Investigator
Amy Moreno, MD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT06295783 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Radiation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06295783 currently recruiting?
Yes, NCT06295783 is actively recruiting participants. Contact the research team at akmoreno@mdanderson.org for enrollment information.
Where is the NCT06295783 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06295783 clinical trial?
NCT06295783 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Amy Moreno, MD at M.D. Anderson Cancer Center. The trial plans to enroll 300 participants.